檢索結果 - Sigve Andersen

Refine Results
  1. 1
    Combination of low vascular endothelial growth factor A (VEGF‐A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer

    Combination of low vascular endothelial growth factor A (VEGF‐A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor... 由 Tom Dønnem, Khalid Al‐Shibli, Sigve Andersen, Samer Al‐Saad, Lill‐Tove Busund, Roy M. Bremnes

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Prognostic Impact of Platelet-Derived Growth Factors in Non-small Cell Lung Cancer Tumor and Stromal Cells

    Prognostic Impact of Platelet-Derived Growth Factors in Non-small Cell Lung Cancer Tumor and Stromal Cells 由 Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Sigve Andersen, Lill‐Tove Busund, Roy M. Bremnes

    出版 2008
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival

    Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival 由 Sigve Andersen, Tom Dønnem, Helge Stenvold, Samer Al‐Saad, Khalid A. Alshibli, Lill‐Tove Busund, Roy M. Bremnes

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence

    High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence 由 Yngve Nordby, Elin Richardsen, Mehrdad Rakaee, Nora Ness, Tom Dønnem, Hiten Patel, Lill‐Tove Busund, Roy M. Bremnes, Sigve Andersen

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy

    CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy 由 Sigurd M. Hald, Roy M. Bremnes, Khalid Al‐Shibli, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Lill‐Tove Busund, Tom Dønnem

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer

    The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer 由 Roy M. Bremnes, Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Sigve Andersen, Rafael Sirera, Carlos Camps, Inigo Marinez, Lill‐Tove Busund

    出版 2010
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  7. 7
    The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer

    The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer 由 Roy M. Bremnes, Khalid Al‐Shibli, Tom Dønnem, Rafael Sirera, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Carlos Camps, Lill‐Tove Busund

    出版 2010
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  8. 8
    Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer

    Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer 由 Mehrdad Rakaee, Lill‐Tove Busund, Erna‐Elise Paulsen, Elin Richardsen, Samer Al‐Saad, Sigve Andersen, Tom Dønnem, Roy M. Bremnes, Thomas K. Kilvaer

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases

    CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases 由 Erna‐Elise Paulsen, Thomas K. Kilvaer, Mehrdad Rakaee, Elin Richardsen, Sigurd M. Hald, Sigve Andersen, Lill‐Tove Busund, Roy M. Bremnes, Tom Dønnem

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure

    High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure 由 Thea Grindstad, Sigve Andersen, Samer Al‐Saad, Tom Dønnem, Yury Kiselev, Christian Melbø‐Jørgensen, Kaja Skjefstad, Lill‐Tove Busund, Roy M. Bremnes, Elin Richardsen

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progression

    Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progression 由 Thea Grindstad, Elin Richardsen, Sigve Andersen, Kaja Skjefstad, Mehrdad Rakaee, Tom Dønnem, Nora Ness, Yngve Nordby, Roy M. Bremnes, Samer Al‐Saad, Lill‐Tove Busund

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival

    Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival 由 Marte Eilertsen, Sigve Andersen, Samer Al‐Saad, Yury Kiselev, Tom Dønnem, Helge Stenvold, Ingvild Pettersen, Khalid Al‐Shibli, Elin Richardsen, Lill‐Tove Busund, Roy M. Bremnes

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort

    The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort 由 Nora Ness, Sigve Andersen, Mehrdad Rakaee, Cecilie Valborg Nordbakken, Andrej Valkov, Erna‐Elise Paulsen, Yngve Nordby, Roy M. Bremnes, Tom Dønnem, Lill‐Tove Busund, Elin Richardsen

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry

    Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry 由 Mehrdad Rakaee, Lill-Tove Rasmussen Busund, Simin Jamaly, Erna‐Elise Paulsen, Elin Richardsen, Sigve Andersen, Samer Al‐Saad, Roy M. Bremnes, Tom Dønnem, Thomas K. Kilvaer

    出版 2019
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Independent and tissue‐specific prognostic impact of miR‐126 in nonsmall cell lung cancer

    Independent and tissue‐specific prognostic impact of miR‐126 in nonsmall cell lung cancer 由 Tom Dønnem, Kenneth Lønvik, Katrine Eklo, Thomas Berg, Sveinung Wergeland Sørbye, Khalid Al‐Shibli, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Roy M. Bremnes, Lill‐Tove Busund

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer

    MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer 由 Tom Dønnem, Christopher G. Fenton, Kenneth Lønvik, Thomas Berg, Katrine Eklo, Sigve Andersen, Helge Stenvold, Khalid Al‐Shibli, Samer Al‐Saad, Roy M. Bremnes, Lill‐Tove Busund

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization

    Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization 由 Tom Dønnem, Katrine Eklo, Thomas Berg, Sveinung Wergeland Sørbye, Kenneth Lønvik, Samer Al‐Saad, Khalid Al‐Shibli, Sigve Andersen, Helge Stenvold, Roy M. Bremnes, Lill‐Tove Busund

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer

    MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer 由 Elin Richardsen, Sigve Andersen, Christian Melbø‐Jørgensen, Mehrdad Rakaee, Nora Ness, Samer Al‐Saad, Yngve Nordby, Mona Irene Pedersen, Tom Dønnem, Roy M. Bremnes, Lill‐Tove Busund

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Stromal Expression of MiR-21 Predicts Biochemical Failure in Prostate Cancer Patients with Gleason Score 6

    Stromal Expression of MiR-21 Predicts Biochemical Failure in Prostate Cancer Patients with Gleason Score 6 由 Christian Melbø‐Jørgensen, Nora Ness, Sigve Andersen, Andrej Valkov, Tom Dønnem, Samer Al‐Saad, Yury Kiselev, Thomas Berg, Yngve Nordby, Roy M. Bremnes, Lill‐Tove Busund, Elin Richardsen

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non–Small Cell Lung Cancer

    The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non–Small Cell Lung Cancer 由 Roy M. Bremnes, Lill‐Tove Busund, Thomas L. Kilvær, Sigve Andersen, Elin Richardsen, Erna Elise Paulsen, Sigurd M. Hald, Mehrdad Rakaee, Wendy A. Cooper, Steven Kao, Tom Dønnem

    出版 2016
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:

檢索工具: